Iavazzo C - Search Results

1

Management of patients with advanced ovarian cancer - Role of complete cytoreduction and HIPEC: Attitudes of gynaecologist oncologists in two different continents.

Spiliotis J, Iavazzo C, Sugarbaker P. Spiliotis J, et al. Among authors: iavazzo c. Aust N Z J Obstet Gynaecol. 2021 Feb;61(1):E1-E2. doi: 10.1111/ajo.13229. Epub 2021 Feb 1. Aust N Z J Obstet Gynaecol. 2021. PMID: 33523489 No abstract available.

2

Hyperthermic intraperitoneal chemotherapy for ovarian cancer: Peritoneal surface disease severity score-preliminary results.

Iavazzo CR, Kopanakis ND, Spiliotis JD. Iavazzo CR, et al. J Surg Oncol. 2018 Sep;118(3):591-592. doi: 10.1002/jso.25142. Epub 2018 Aug 24. J Surg Oncol. 2018. PMID: 30144064 No abstract available.

3

Hyperthermic intraperitoneal chemotherapy (HIPEC) for ovarian cancer: a "useless intraoperative fever" or the next hot voice in the surgical management of the "silent killer"?

Iavazzo C, Spiliotis J. Iavazzo C, et al. Arch Gynecol Obstet. 2018 Oct;298(4):673-674. doi: 10.1007/s00404-018-4877-3. Arch Gynecol Obstet. 2018. PMID: 30145687

4

Secondary debulking for ovarian carcinoma relapse: The R-R dilemma – is the prognosis different for residual or recurrent disease?

Spiliotis JD, Iavazzo C, Kopanakis ND, Christopoulou A. Spiliotis JD, et al. Among authors: iavazzo c. J Turk Ger Gynecol Assoc. 2019 Nov 28;20(4):213-217. doi: 10.4274/jtgga.galenos.2019.2018.0165. Epub 2019 Jul 31. J Turk Ger Gynecol Assoc. 2019. PMID: 31362486 Free PMC article.

5

Prognostic significance of ovarian metastases (macroscopic or microscopic) in patients with colorectal cancer undergoing cytoreduction followed by HIPEC.

Iavazzo C, Spiliotis J. Iavazzo C, et al. Int J Colorectal Dis. 2020 Jul;35(7):1335-1336. doi: 10.1007/s00384-020-03613-y. Epub 2020 May 3. Int J Colorectal Dis. 2020. PMID: 32363478 No abstract available.

6

Is there a promising role of HIPEC in patients with advanced mucinous ovarian cancer?

Iavazzo C, Spiliotis J. Iavazzo C, et al. Arch Gynecol Obstet. 2021 Feb;303(2):597-598. doi: 10.1007/s00404-020-05636-w. Epub 2020 Jun 8. Arch Gynecol Obstet. 2021. PMID: 32514757 No abstract available.

7

Clinical findings of patients with pseudomyxoma peritonei of appendiceal origin undergoing Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC).

Iavazzo C, Spiliotis J. Iavazzo C, et al. Updates Surg. 2020 Sep;72(3):923-924. doi: 10.1007/s13304-020-00842-2. Epub 2020 Jun 29. Updates Surg. 2020. PMID: 32602012 No abstract available.

8

Survey on the current gynaecological approach of ovarian cancer patients: The utility of HIPEC.

Iavazzo C, Fotiou A, Tsiatas M, Christopoulou A, Spiliotis J, Sugarbaker P. Iavazzo C, et al. Pleura Peritoneum. 2020 Feb 26;5(1):20190029. doi: 10.1515/pp-2019-0029. eCollection 2020 Mar 1. Pleura Peritoneum. 2020. PMID: 32821775 Free PMC article.

9

Upfront or intermediate treatment of advanced ovarian cancer patients with cytoreduction plus HIPEC: Results of a retrospective study.

Spiliotis J, Iavazzo C, Fotiou A, Kopanakis N, Terra A, Efstathiou E, Margari C, Tsiatas M. Spiliotis J, et al. Among authors: iavazzo c. J Surg Oncol. 2021 Feb;123(2):630-637. doi: 10.1002/jso.26280. Epub 2020 Oct 30. J Surg Oncol. 2021. PMID: 33125733

10

Is there a role of repeat cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with relapse from peritoneal metastatic disease? A survival analysis.

Spiliotis J, Prodromidou A, Ferfelis M, Iavazzo C, Tsiatas M, Vaxevanidou A, Metaxas T. Spiliotis J, et al. Among authors: iavazzo c. J BUON. 2020 Sep-Oct;25(5):2504-2509. J BUON. 2020. PMID: 33277875 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

294 results

Search Page

Filters